PointState Capital LP Q1 2017 Filing

Filed May 15, 2017

Portfolio Value

$9.6T

Holdings

128

Report Date

Q1 2017

Filing Type

13F-HR

All Holdings (128 positions)

#StockSharesValue% PortfolioType
101
BWXTBwx Technologies Inc
200,000$9.5B0.10%
102
CHRSCoherus Biosciences Inc
421,300$8.9B0.09%
103
Axovant Sciences Ltd
576,400$8.6B0.09%
104
EOGEog Res Inc
86,350$8.4B0.09%
105
HBANHuntington Bancshares Inc
605,500$8.1B0.08%
106
Ignyta Inc
706,200$6.1B0.06%
107
RVNCEURRevance Therapeutics Inc
276,500$5.8B0.06%
108
2L9Blueprint Medicines Corp
129,500$5.2B0.05%
109
Reynolds American Inc
80,000$5.0B0.05%
110
BUWABio Rad Labs Inc
20,100$4.0B0.04%
111
Loxo Oncology Inc
91,600$3.9B0.04%
112
NIHDEURNii Hldgs Inc
2,894,900$3.8B0.04%
113
VVisa Inc
39,700$3.5B0.04%
114
BABAAlibaba Group Hldg Ltd
30,600$3.3B0.03%
115
SNYSanofi
7,305,164$3.3B0.03%
116
Syngenta Ag
35,000$3.1B0.03%
117
BACVerizon Communications Inc
50,000$2.4B0.03%
118
CMAComerica Inc
30,300$2.1B0.02%
119
XLVSelect Sector Spdr Tr
25,000$1.9B0.02%Put
120
CICigna Corporation
12,500$1.8B0.02%
121
Versartis Inc
83,417$1.8B0.02%
122
Computer Sciences Corp
25,000$1.7B0.02%Put
123
PXDEURPioneer Nat Res Co
5,300$987.0M0.01%
124
UEOWestlake Chem Corp
13,700$905.0M0.01%
125
HALHalliburton Co
18,000$886.0M0.01%
126
UALUnited Contl Hldgs Inc
12,100$855.0M0.01%
127
Oncobiologics Inc
100,000$80.0M0.00%
128
Oncobiologics Inc
100,000$50.0M0.00%
PreviousPage 2 of 2